Complete Filing Data
Fusemachines Inc. reported Stockholders Equity of -$14.58 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fusemachines Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income Loss | -$928.0K | -$15.4M |
| Operating Income Loss | -$6.0M | -$8.2M |
| Operating Expenses | $10.3M | $13.0M |
| General And Administrative Expense | $8.2M | $10.3M |
| Other Nonoperating Income Expense | $220.0K | -$148.0K |
| Nonoperating Income Expense | $5.0M | -$7.2M |
| Selling And Marketing Expense | $1.4M | $2.0M |
| Revenues | $7.7M | $8.8M |
| Research And Development Expense | $720.0K | $732.0K |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $10.0K | $57.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From AOCI Realized Upon Sale Or Liquidation Net Of Tax | -$10.0K | -$57.0K |
| Interest Income Expense Net | -$268.0K | -$234.0K |
| Income Taxes Paid Net | $31.0K | $10.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$925.0K | -$15.4M |
| Cost Of Revenue | $3.4M | $4.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$19.8M | -$203.9K | -$2.1M | -$132.9K | $422.5K | $148.1K |
| Operating Income Loss | -$1.1M | -$613.0K | ||||
| Operating Expenses | $1.1M | $613.0K | ||||
| General And Administrative Expense | $30.0K | $30.0K | ||||
| Other Nonoperating Income Expense | ||||||
| Nonoperating Income Expense | -$18.7M | $480.1K | ||||
| Selling And Marketing Expense | ||||||
| Revenues | ||||||
| Research And Development Expense | ||||||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | ||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From AOCI Realized Upon Sale Or Liquidation Net Of Tax | ||||||
| Interest Income Expense Net | ||||||
| Income Taxes Paid Net | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | ||||||
| Cost Of Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity * | -$14.6M | -$24.3M | -$8.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.7M | $234.0K | |
| Retained Earnings Accumulated Deficit | -$35.1M | -$34.2M | |
| Liabilities And Stockholders Equity | $7.5M | $5.5M | |
| Liabilities | $22.1M | $29.9M | |
| Assets | $7.5M | $5.5M | |
| Accounts Payable Current | $5.0M | $6.5M | |
| Cash And Cash Equivalents At Carrying Value | $4.2M | $500.0K | |
| Preferred Stock Value | $7.9M | ||
| Liabilities Current | $20.0M | $20.3M | |
| Assets Current | $6.3M | $4.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.2M | $500.0K | $266.0K |
| Notes Payable Current | |||
| Marketable Securities Current | |||
| Interest Payable Current | |||
| Deferred Compensation Liability Current | |||
| Accrued Liabilities Current | |||
| Common Stock Value | $3.0K | $1.0K | |
| Unpaid Deferred Transaction Costs As Of End Of Period | $242.0K | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$42.6M | -$11.6M | -$11.2M | -$10.7M | -$10.2M | -$9.5M | -$9.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | |||||||
| Retained Earnings Accumulated Deficit | -$32.9M | ||||||
| Liabilities And Stockholders Equity | $12.4M | ||||||
| Liabilities | $43.9M | ||||||
| Assets | $12.4M | ||||||
| Accounts Payable Current | $351.5K | ||||||
| Cash And Cash Equivalents At Carrying Value | |||||||
| Preferred Stock Value | |||||||
| Liabilities Current | $43.9M | ||||||
| Assets Current | $12.4M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $9.3K | $47.4K | |||||
| Notes Payable Current | $3.7M | $2.8M | |||||
| Marketable Securities Current | $12.3M | $16.1M | |||||
| Interest Payable Current | $242.2K | $129.6K | |||||
| Deferred Compensation Liability Current | $6.6M | $6.6M | |||||
| Accrued Liabilities Current | $1.9M | $968.6K | |||||
| Common Stock Value | |||||||
| Unpaid Deferred Transaction Costs As Of End Of Period |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$5.5M | -$2.2M |
| Net Cash Provided By Used In Investing Activities | -$165.0K | -$176.0K |
| Net Cash Provided By Used In Financing Activities | $9.4M | $2.6M |
| Increase Decrease In Prepaid Expense | $74.0K | $85.0K |
| Increase Decrease In Accrued Liabilities | $34.0K | $1.7M |
| Increase Decrease In Accounts Payable | -$200.0K | $3.7M |
| Proceeds From Repayments Of Related Party Debt | -$700.0K | $700.0K |
| Payments For Repurchase Of Common Stock | $2.0M | |
| Share Based Compensation | $231.0K | $1.1M |
| Increase Decrease In Unbilled Revenue | -$82.0K | $39.0K |
| Increase Decrease In Other Current Assets | -$22.0K | $2.0K |
| Increase Decrease In Operating Lease Liability | -$73.0K | -$87.0K |
| Increase Decrease In Deferred Revenue | -$54.0K | $33.0K |
| Increase Decrease In Accounts Receivable | -$47.0K | $904.0K |
| Increase Decrease In Accounts And Other Receivables | -$4.0K | -$18.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 6.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 6.0M | |
| Preferred Stock Shares Issued | 6.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Common Stock Shares Issued | 29.4M | 7.7M |
| Weighted Average Number Of Shares Outstanding Basic | 11.5M | 7.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 11.5M | 7.0M |
| Earnings Per Share Diluted | $-0.08 | $-2.21 |
| Earnings Per Share Basic | $-0.08 | $-2.21 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Preferred Stock Shares Authorized | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 |
| Preferred Stock Shares Issued | 0.00 |
| Common Stock Par Or Stated Value Per Share | |
| Common Stock Shares Issued | |
| Weighted Average Number Of Shares Outstanding Basic | |
| Weighted Average Number Of Diluted Shares Outstanding | |
| Earnings Per Share Diluted | |
| Earnings Per Share Basic |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Adjustment To Additional Capital Waiver Of Administrative Service Fees | ||
| Professional Fees | ||
| Policyholder Benefits And Claims Incurred Net | ||
| Investment Income Dividend | ||
| Dues And Subscriptions | ||
| Additional Paid In Capital | $31.3M | $4.7M |
| Prepaid Expense Current | ||
| Stock Redeemed Or Called During Period Value | ||
| Provision For Doubtful Accounts | $55.0K | $540.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Adjustment To Additional Capital Waiver Of Administrative Service Fees | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | |
| Professional Fees | $884.8K | $432.3K | |||||
| Policyholder Benefits And Claims Incurred Net | $45.0K | $50.1K | |||||
| Investment Income Dividend | $134.8K | $480.1K | |||||
| Dues And Subscriptions | $130.8K | $73.4K | |||||
| Additional Paid In Capital | $1.3M | ||||||
| Prepaid Expense Current | $21.5K | $6.7K | |||||
| Stock Redeemed Or Called During Period Value | -$209.8K | -$260.5K | -$258.6K | -$610.1K | -$899.7K | -$889.3K | |
| Provision For Doubtful Accounts |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.